Nemaura Medical announced the appointment of Nikolai Rozanov as strategic adviser in AI development. Rozanov is a specialist in the field of artificial intelligence and was selected for inclusion by Forbes magazine in their ’30 Under 30′ list in the field of technology. The company said, “The appointment of Mr Rozanov solidifies the Company’s expertise in the growing AI sector, at a time when AI developments in healthcare are gathering pace. The Company is now well placed to further integrate data from its CGM to create tailored programs that can make tailored personalised recommendations.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NMRD:
- Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
- Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
- Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
- Nemaura Medical provides update on Nasdaq compliance status, process
- Nemaura announces interim results from collaboration with UK National Health